Industry News
Non-Melanoma Skin Cancer Linked To Future Risk Of Other Forms Of Cancers
Apr 23, 2013
White people who have types of skin cancer other than melanoma (non-melanoma skin cancer) may be at increased risk of having other forms of cancer in the future, according to a study by US researchers published in this week's PLOS Medicine. The analysis, led by Dr... Read More
Obese Men With Benign Biopsy At High Risk For Prostate Cancer
Apr 23, 2013
Data on obesity and prostate cancer conflict. Precancerous lesions were more common in benign biopsy specimens from obese men. After benign biopsy, obese men at higher risk for future prostate cancer... Read More
Intensity Modulated Radiotherapy Reduces Side Effects In Patients With Early Breast Cancer
Apr 23, 2013
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO)... Read More
Hope For New Tailor-Made Anti-Cancer Agents
Apr 23, 2013
Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients. The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent... Read More
Sweeping Study Of Cancer Metabolism Identifies Hundreds Of Alterations And Potential Drug Targets To Starve Tumors
Apr 23, 2013
A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer. The analysis, conducted by researchers at Columbia University Medical Center, also identified hundreds of potential drug targets that could cut off a tumor's fuel supply or interfere with its ability to synthesize essential building blocks... Read More
Discovery Upends Model For How Dividing Cells Monitor The Equal Distribution Of Their Chromosomes, A Process That Often Runs Awry In Cancer
Apr 23, 2013
Ludwig researchers Arshad Desai and Christopher Campbell, a post-doctoral fellow in his laboratory, were conducting an experiment to parse the molecular details of cell division about three years ago, when they engineered a mutant yeast cell as a control that, in theory, had no chance of surviving. Apparently unaware of this, the mutant thrived... Read More
New Potential Target For Cancer Therapy Identified
Apr 23, 2013
Researchers at UT Southwestern Medical Center have found that alternative splicing - a process that allows a single gene to code for multiple proteins - appears to be a new potential target for anti-telomerase cancer therapy. The enzyme telomerase is overexpressed in almost all cancer cells, and previous research efforts have failed to identify good telomerase inhibitors. The study by Dr... Read More
Proliferation Of Two Breast Cancer Lines Stymied By Low-Dose Aspirin
Apr 23, 2013
Regular use of low-dose aspirin may prevent the progression of breast cancer, according to results of a study by researchers at the Veterans Affairs Medical Center in Kansas City, Mo., and the University of Kansas Medical Center. The study found that aspirin slowed the growth of breast cancer cell lines in the lab and significantly reduced the growth of tumors in mice... Read More
Research Suggests 'Chemo Brain' May Involve Neurophysiological Change
Apr 23, 2013
For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment. Whether this mental "fogginess" is psychosomatic or reflects underlying changes in brain function has been a bone of contention among scientists and physicians. Now, a new study led by Dr... Read More
Tumor Growth In Breast Cancer And Angiosarcoma Inhibited By Novel Monoclonal Antibody
Apr 23, 2013
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma... Read More
Previous Page Next Page